Douglas Flora: Current issue of AI in Precision Oncology is ready for consumption
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, reshared a post by Jan Beger, Global Head of AI Advocacy at GE HealthCare, on LinkedIn, adding:
“We are proud of what we are building at AI in Precision Oncology.
A special thank you to our publisher partners—Marianne Russell, Sophie Reisz, Bill Levine, Bob Vrooman, and the entire team at Mary Ann Liebert, Inc.—for recognizing the crucial role these tools will soon play in our world and for your commitment to bridging the gap between the technologies and the providers who may not yet realize their need.
It’s an exciting time to share that our current issue is ready for consumption, and our next one is about to go to press. This is my favorite time to look ahead and announce a CALL FOR PAPERS!
If you have a concept you would like to propose as an invited editorial frontmatter, please DM me. Additionally, consider us for timely peer review and publication of your manuscripts.
As our impact expands, I would also love to connect with any companies looking to advertise or market to our audiences through journal ads, webinars, special issues, etc.
Feel free to reach out to me directly if you would like to discuss any of these opportunities. The fun is just getting started, as you can see from Jan Beger‘s great post below!”
Quoting Jan Beger‘s post:
“This paper analyzes the evolution of AI in healthcare over the past 30 years through a bibliometric study of 22,950 publications.
- AI research in healthcare has grown exponentially, with an average annual growth rate of 26.97% and 6,450 publications in 2023, up from just 15 in 1995.
- The US (28,663 articles) and China (12,740 articles) are the top contributors, with Harvard University leading institutional output (1,690 articles).
- PLOS ONE (370 articles), IEEE Access (360), and Scientific Reports (358) are the top journals publishing AI healthcare research.
- Neural networks, decision support systems, and medical records management are dominant AI applications, with decision support research rising steadily from 2012 to 2022.
- ChatGPT-related research has surged, with all top five most cited AI healthcare papers in 2023 focusing on ChatGPT’s role in education, clinical practice, and research.
- The most cited AI review paper, “Machine learning: Trends, Perspectives, and Prospects” by Jordan & Mitchell (2015), has 3,642 citations.
- China leads in AI healthcare patents, filing 648,000 applications from 2018-2022, far surpassing the US and South Korea.
- AI played a critical role in COVID-19 research, including virus tracing, drug discovery, and diagnostic tools like COVID-Net for chest X-ray analysis.
- Blockchain integration in AI healthcare is expanding, offering secure data sharing, privacy protection, and medical record management solutions.
- Future AI growth in healthcare requires stronger ethical frameworks, regulatory oversight, and global collaboration to balance innovation with responsible adoption.
Xie Y, Zhai Y, Lu G. Evolution of artificial intelligence in healthcare: a 30-year bibliometric study. Front. Med. 2025. DOI: 10.3389/fmed.2024.1505692.”
Evolution of artificial intelligence in healthcare: a 30-year bibliometric study.
Authors: Yaojue Xie, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023